Renal Dialysis

• 

  Subject Areas on Research

  • A Peer-to-Peer Mentoring Program for In-Center Hemodialysis: A Patient-Centered Quality Improvement Program. 
  • A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. 
  • A Quality Improvement Intervention to Improve the Efficiency of Arteriovenous Access Placement for Pre-Dialysis Inpatients. 
  • A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. 
  • A comparison of HIV-positive patients with and without infective endocarditis: an echocardiographic study--the Emory Endocarditis Group experience. 
  • A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis. 
  • A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. 
  • A large-scale study of the upper arm basilic transposition for hemodialysis. 
  • A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 
  • A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. 
  • A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients. 
  • A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. 
  • A pilot study using an implantable device to characterize cardiac arrhythmias in hemodialysis patients: implications for future research. 
  • A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease. 
  • A quality improvement program for hemodialysis vascular access. 
  • ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. 
  • ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients. 
  • ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. 
  • Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. 
  • Accessory veins in nonmaturing autogenous arteriovenous fistulae: analysis of anatomic features and impact on fistula maturation. 
  • Activated injectable vitamin D and hemodialysis survival: a historical cohort study. 
  • Acute decompensation after removing a central line: practical approaches to increasing safety in the intensive care unit. 
  • Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. 
  • Acute kidney transplant failure following transurethral bladder polyp fulguration. 
  • Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. 
  • Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. 
  • Acute renal failure in recipients of organ transplantation and nontransplantation patients: comparison of characteristics and mortality. 
  • Acute tubular necrosis; analysis of one hundred cases with respect to mortality, complications, and treatment with and without dialysis. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Advance care planning with patients on hemodialysis: an implementation study. 
  • Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. 
  • Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients. 
  • Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. 
  • Amphotericin B therapy in an anephric patient. 
  • An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. 
  • Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. 
  • Analysis of infection risk following covered stent exclusion of pseudoaneurysms in prosthetic arteriovenous hemodialysis access grafts. 
  • Anemia as a risk factor and therapeutic target in heart failure. 
  • Annual wellness visits and care management before and after dialysis initiation. 
  • Antibiotic prophylaxis for hemodialysis access placement. 
  • Antibodies to prothrombin, factor V, and beta2-glycoprotein I and vascular access thrombosis. 
  • Antibodies to topical bovine thrombin correlate with access thrombosis. 
  • Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis. 
  • Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. 
  • Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Arterial compliance in adolescents and young adults receiving chronic hemodialysis. 
  • Arterial steal syndrome. 
  • Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. 
  • Arteriovenous Graft Delamination and Dissection as a Cause of Graft Dysfunction. 
  • Arteriovenous Graft Failure in the Veterans Health Administration: Outcome Disparities Associated with Race. 
  • Assessment of Spending for Patients Initiating Dialysis Care. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. 
  • Association between patient race and staff resuscitation efforts after cardiac arrest in outpatient dialysis clinics: A study from the CARES surveillance group. 
  • Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. 
  • Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis. 
  • Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission. 
  • Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation. 
  • Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults. 
  • Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation. 
  • Association of VA Payment Reform for Dialysis with Spending, Access to Care, and Outcomes for Veterans with ESKD. 
  • Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. 
  • Association of insurance status with timing of hemodialysis access placement. 
  • Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. 
  • At the Crossroads for Intravenous Iron Dosing. 
  • Authors' Reply. 
  • Authors' Reply. 
  • Authors' Reply. 
  • Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. 
  • Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. 
  • Baclofen Toxicity in Kidney Disease. 
  • Bacterial endocarditis in hemodialysis patients. 
  • Barriers and Facilitators to Performing Cardiopulmonary Resuscitation During Treatment in Outpatient Hemodialysis Clinics: A Qualitative Study. 
  • Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. 
  • Beta-lactam antibiotic-induced pseudoporphyria. 
  • Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. 
  • Bilateral nephrectomy by the posterior approach. 
  • Bioengineered hemodialysis access grafts. 
  • Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. 
  • Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation. 
  • Biomarkers of vascular calcification and mortality in patients with ESRD. 
  • Biopsychosocial experiences and coping strategies of elderly ESRD patients: a qualitative study to inform the development of more holistic and person-centred health services in Singapore. 
  • Blood flow distribution in sorbent beds: analysis of a new sorbent device for hemoperfusion. 
  • Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients. 
  • Breaking the cycle of functional decline in older dialysis patients. 
  • Calciphylaxis. 
  • Can an arteriovenous dialysis access be salvaged when a clinically significant steal develops? 
  • Carbon tetrachloride poisoning treated with hemodialysis and total parenteral nutrition. 
  • Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency. 
  • Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. 
  • Cardiovascular Outcomes Reported in Hemodialysis Trials. 
  • Care of the Pediatric Patient on Chronic Dialysis. 
  • Care of the pediatric patient on chronic peritoneal dialysis. 
  • Catheter access for hemodialysis: an overview. 
  • Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. 
  • Catheter-related bacteremia in patients undergoing hemodialysis. 
  • Cause Unknown, Treatment Uncertain, Outcome Poor: An Encounter With Kidney Failure in the Developing World. 
  • Challenges and novel therapies for vascular access in haemodialysis. 
  • Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. 
  • Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study. 
  • Changing patient characteristics and the effect on mortality in endocarditis. 
  • Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. 
  • Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. 
  • Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia. 
  • Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis. 
  • Cholesterol atheroembolic renal disease. Report of 3 cases with emphasis on diagnosis by skin biopsy and extended survival. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. 
  • Chronic renal failure in infants and children. 
  • Chronic salicylism resulting in noncardiogenic pulmonary edema requiring hemodialysis. 
  • Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. 
  • Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. 
  • Classifying individuals based on a densely captured sequence of vital signs: An example using repeated blood pressure measurements during hemodialysis treatment. 
  • Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists. 
  • Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. 
  • Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. 
  • Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Comparative Assessment of Utilization and Hospital Outcomes of Veterans Receiving VA and Non-VA Outpatient Dialysis. 
  • Comparative analysis of antifibrinolytic medications in pediatric heart surgery. 
  • Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. 
  • Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. 
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 
  • Comparing Mortality of Peritoneal and Hemodialysis Patients in an Era of Medicare Payment Reform. 
  • Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. 
  • Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. 
  • Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers. 
  • Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. 
  • Continuous arteriovenous hemodialysis: effect of dialyzer geometry. 
  • Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. 
  • Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. 
  • Coping strategies utilized by adolescents with end stage renal disease 
  • Coping with fluid restriction and the quality of life in hemodialysis patients with very low or no daily urine output. 
  • Coronary artery bypass grafting in patients with dialysis-dependent renal failure. 
  • Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula. 
  • Correction of central venous stenoses: use of angioplasty and vascular Wallstents. 
  • Correlates of ADL difficulty in a large hemodialysis cohort. 
  • Correlates of left ventricular mass in chronic hemodialysis recipients. 
  • Cost of achieving equivalent outcomes in sicker patients after liver transplant. 
  • Costoclavicular venous decompression in patients with threatened arteriovenous hemodialysis access. 
  • Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Cryptococcal infection of a prosthetic dialysis fistula. 
  • Cytomegalovirus infection and chronic hemodialysis. 
  • Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply. 
  • Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. 
  • Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. 
  • Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. 
  • Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. 
  • Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access. 
  • Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. 
  • Delivery of a patient-friendly functioning report to improve patient-centeredness of dialysis care: a pilot study. 
  • Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. 
  • Depression in patients with chronic kidney disease on dialysis in Saudi Arabia. 
  • Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis. 
  • Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. 
  • Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. 
  • Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records. 
  • Determinants of regret in elderly dialysis patients. 
  • Development of an Administrative Data-Based Frailty Index for Older Adults Receiving Dialysis. 
  • Development, implementation and user experience of the Veterans Health Administration (VHA) dialysis dashboard. 
  • Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk. 
  • Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. 
  • Dialysate potassium concentration: Should mass balance trump electrophysiology? 
  • Dialysis Facility Profit Status and Early Steps in Kidney Transplantation in the Southeastern United States. 
  • Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. 
  • Dialysis access infections. 
  • Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States. 
  • Dialysis or transplantation: fitting the treatment to the patient. 
  • Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis. 
  • Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. 
  • Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. 
  • Disparities in Discussions about Kidney Replacement Therapy in CKD Care. 
  • Disparities in the burden, outcomes, and care of chronic kidney disease. 
  • Do cardiac troponins provide prognostic insight in hemodialysis patients? 
  • Do income level and race influence survival in patients receiving hemodialysis? 
  • Drawing Attention to Potentially Inappropriate Medications for Older Adults Receiving Dialysis. 
  • Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation. 
  • Effect of Direct Contact on the Phytotoxicity of Silver Nanomaterials. 
  • Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. 
  • Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. 
  • Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. 
  • Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. 
  • Effect of dialysate composition on the lipid response to L-carnitine supplementation. 
  • Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. 
  • Effect of dipyridamole plus aspirin on hemodialysis graft patency. 
  • Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. 
  • Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study. 
  • Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. 
  • Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 
  • Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial. 
  • Efficiency and outcomes of emergent vascular access procedures performed at a dedicated outpatient vascular access center. 
  • End-stage renal disease and intensive care unit prognosis: are current tools good enough? 
  • End-stage renal disease in nursing homes: a systematic review. 
  • End-stage renal disease treatment options education: What matters most to patients and families. 
  • Endovascular aortic aneurysm repair with carbon dioxide-guided angiography in patients with renal insufficiency. 
  • Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. 
  • Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure. 
  • Evaluation of disease-state management of dialysis patients. 
  • Evaluation of repeat distal transradial access in the anatomic snuffbox. 
  • Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease. 
  • Examining the heterogeneity inexcess risks of coronary heart disease, stroke, dialysis, and lower extremity amputation associated with type 2 diabetes mellitus across demographic subgroups in an Asian population: A population-based matched cohort study. 
  • Expanded criteria donors/high risk recipients is not always cheaper than hemodialysis. 
  • Exploring the challenges and needs of home caregivers of hemodialysis patients in the Philippines: A mixed methods study. 
  • Facility-Level Factors and Racial Disparities in Cardiopulmonary Resuscitation within US Dialysis Clinics. 
  • Facility-Level Variation in Dialysis Use and Mortality Among Older Veterans With Incident Kidney Failure. 
  • Factors influencing function of temporary dialysis catheters. 
  • Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy. 
  • Family dynamics in a multi-ethnic Asian society: comparison of elderly CKD patients and their family caregivers experience with medical decision making for managing end stage kidney disease. 
  • Feasibility and benefits of exercise training in patients on maintenance dialysis. 
  • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. 
  • Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. 
  • Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. 
  • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. 
  • Fibroblast growth factor 23 and the future of phosphorus management. 
  • Fistula dysfunction: effect on rapid hemodialysis. 
  • Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II. 
  • Foot problems in the diabetic transplant recipient. 
  • Forearm versus upper arm grafts for vascular access. 
  • Fragmentation of care as a barrier to optimal ESKD management. 
  • Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States. 
  • Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. 
  • Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. 
  • HIV in the dialysis population: Current issues and future directions. 
  • HIV-1 dynamics in haemodialysis patients. 
  • Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. 
  • Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. 
  • Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients. 
  • Have racial disparities in home dialysis utilization changed over time? 
  • Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. 
  • Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. 
  • Hemodialysis Reliable Outflow device impingement in the subclavian position: a case report. 
  • Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. 
  • Hemodialysis catheter integrity during mechanical power injection of iodinated contrast medium for computed tomography angiography. 
  • Hemodialysis vascular access: effect on urea kinetics and the dialysis prescription. 
  • Hemodialysis-associated subclavian vein stenosis. 
  • Hemodynamic changes during dialysis. 
  • Hemodynamic changes during hemodialysis: role of dialyzate. 
  • Hemodynamics of distal revascularization-interval ligation. 
  • Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients. 
  • Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis. 
  • Hepatitis B vaccines in patients with chronic renal failure before dialysis. 
  • Hereditary thrombotic thrombocytopenic purpura: microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations. 
  • High-dose IV iron for anemia correction in chronic kidney disease. 
  • Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target? 
  • Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. 
  • Hypercalcemia in a dialysis patient. 
  • Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. 
  • Hyperkalemia: treatment options. 
  • Iatrogenic Baclofen Neurotoxicity in ESRD: Recognition and Management. 
  • Idarucizumab for dabigatran overdose. 
  • Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. 
  • Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessment. 
  • Impact of activated vitamin D and race on survival among hemodialysis patients. 
  • Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. 
  • Impact of pre-dialysis nephrology care engagement and decision-making on provider and patient action toward permanent vascular access. 
  • Impact of preoperative renal dysfunction in patients undergoing off-pump versus on-pump coronary artery bypass. 
  • Implantable Defibrillators for Primary Prevention of Sudden Death in Patients on Dialysis. 
  • Implementation of the Dialysis Outcomes Quality Initiative Vascular Access Guidelines. 
  • Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population. 
  • Improving Access to Kidney Transplantation: Business as Usual or New Ways of Doing Business? 
  • Improving Patient Experience and Treatment Adherence in the Adult, Outpatient Hemodialysis Population. 
  • Improving survival of octogenarian patients selected for haemodialysis. 
  • In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. 
  • In-Hospital Cardiac Arrest Resuscitation Practices and Outcomes in Maintenance Dialysis Patients. 
  • Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. 
  • Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. 
  • Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. 
  • Increased risk of Staphylococcus aureus bacteremia in hemodialysis-A nationwide study. 
  • Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients. 
  • Infective Endocarditis in Patients on Chronic Hemodialysis. 
  • Inflammation and the paradox of racial differences in dialysis survival. 
  • Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. 
  • Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. 
  • Inhibitor of marrow thymidine incorporation from sera of patients with uremia. 
  • Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. 
  • Intellectual functioning in renal failure and chronic dialysis. 
  • Intensity of renal support in critically ill patients with acute kidney injury. 
  • Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. 
  • Intradialytic hypertension and its association with endothelial cell dysfunction. 
  • Intravenous iron administration strategies and anemia management in hemodialysis patients. 
  • Intravenous iron exposure and mortality in patients on hemodialysis. 
  • Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. 
  • John Henryism and Perceived Health among Hemodialysis Patients in a Multiracial Brazilian Population: the PROHEMO. 
  • Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study. 
  • Klotho variants and chronic hemodialysis mortality. 
  • Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. 
  • Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review. 
  • Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longitudinal study of neuropsychological functioning in patients on chronic hemodialysis: a preliminary report. 
  • Maintenance of permanent hemodialysis vascular access patency. 
  • Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review. 
  • Managing older adults with CKD: individualized versus disease-based approaches. 
  • Managing the complications of plasma cell myeloma. 
  • Market Consolidation and Innovation in US Dialysis. 
  • Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. 
  • Medical safety in the care of the person with end-stage kidney disease. 
  • Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016. 
  • Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis. 
  • Metastatic complications of bloodstream infections in hemodialysis patients. 
  • Methoxyflurane-induced renal dysfunction. 
  • Microvascular dilatation after haemodialysis is determined by the volume of fluid removed and fall in mean arterial pressure. 
  • Minding the gap and overlap: a literature review of fragmentation of primary care for chronic dialysis patients. 
  • Mitral procedure selection in patients on dialysis: does mitral repair influence outcomes? 
  • Mobile intracardiac calcinosis: risk of thromboembolism in patients with haemodialysed end stage renal disease. 
  • Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. 
  • Mortality Risk Factors among Infants Receiving Dialysis in the Neonatal Intensive Care Unit. 
  • Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke. 
  • Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States. 
  • Multi-center experience of 164 consecutive Hemodialysis Reliable Outflow [HeRO] graft implants for hemodialysis treatment. 
  • Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. 
  • Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. 
  • Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. 
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. 
  • National Trends in the Association of Race and Ethnicity With Predialysis Nephrology Care in the United States From 2005 to 2015. 
  • Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. 
  • Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients. 
  • No heroic measures: how soon is too soon to stop? 
  • Non-A, non-B hepatitis and chronic dialysis--another dilemma. 
  • Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. 
  • Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. 
  • Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure. 
  • Nursing, Diabetes, Hemodialysis and COVID-19. 
  • Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. 
  • Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease. 
  • Operative and perioperative management of infected arteriovenous grafts. 
  • Opioid Use in Hemodialysis Patients. 
  • Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect. 
  • Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. 
  • Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. 
  • Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease. 
  • Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. 
  • Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. 
  • Outcomes of prosthetic hemodialysis grafts after deployment of bare metal versus covered stents at the venous anastomosis. 
  • Paradoxical embolus following percutaneous thrombectomy of hemodialysis reliable outflow graft. 
  • Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. 
  • Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. 
  • Patient Outcomes and Dialysis Consolidation-Two Big to Fail? 
  • Patient Preferences for Waiting Time and Kidney Quality. 
  • Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. 
  • Patient mortality in chronic dialysis: comparisons between hemodialysis and peritoneal dialysis. 
  • Patient-Reported Outcome Instruments for Physical Symptoms Among Patients Receiving Maintenance Dialysis: A Systematic Review. 
  • Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. 
  • Patient-reported outcomes in hemodialysis vascular access: A call to action. 
  • Patients with Fabry disease on dialysis in the United States. 
  • Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. 
  • Payer Mix Among Patients Receiving Dialysis-Reply. 
  • Perceived barriers and facilitators to chronic kidney disease care among patients in Singapore: a qualitative study. 
  • Percutaneous interventions on the hemodialysis reliable outflow vascular access device. 
  • Perioperative coagulation management in the intensive care unit. 
  • Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. 
  • Peripheral neuropathy in patients with chronic renal failure. A treatable source of discomfort and disability. 
  • Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education. 
  • Perspectives on decision making amongst older people with end-stage renal disease and caregivers in Singapore: A qualitative study. 
  • Phosphorus binders and survival on hemodialysis. 
  • Physician access and early nephrology care in elderly patients with end-stage renal disease. 
  • Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. 
  • Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis. 
  • Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine. 
  • Plasma gelsolin and circulating actin correlate with hemodialysis mortality. 
  • Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses within Failing Prosthetic Arteriovenous Grafts. 
  • Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty. 
  • Postoperative oxycodone toxicity in a patient with chronic pain and end-stage renal disease. 
  • Predialysis health, dialysis timing, and outcomes among older United States adults. 
  • Predialysis systolic BP variability and outcomes in hemodialysis patients. 
  • Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. 
  • Predicting mortality over different time horizons: which data elements are needed? 
  • Predictive value of access blood flow and stenosis in detection of graft failure. 
  • Predictive value of access blood flow in detecting access thrombosis. 
  • Predictors of loss of residual renal function among new dialysis patients. 
  • Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender. 
  • Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. 
  • Predisposition to arrhythmias: electrolytes, uremic fibrosis, other factors. 
  • Preferences for current health and their association with outcomes in patients with kidney disease. 
  • Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. 
  • Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses. 
  • Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. 
  • Private Equity Acquisition And Responsiveness To Service-Line Profitability At Short-Term Acute Care Hospitals. 
  • Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. 
  • Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. 
  • Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. 
  • Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. 
  • Prospective study of depression among dialysis patients in Saudi Arabia. 
  • Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. 
  • Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. 
  • Pseudogout in a patient on renal dialysis. 
  • Psychometric Evaluation of the Filipino Versions of the Duke University Religion Index and the Spiritual Coping Strategies Scale in Filipino Hemodialysis Patients. 
  • Psychometric properties of the Persian spiritual coping strategies scale in hemodialysis patients. 
  • Pyrogenic reactions in hemodialysis patients, Hanoi, Vietnam. 
  • Quality of life in older adults receiving hemodialysis: a qualitative study. 
  • Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. 
  • Radiation hand exposure during restoration of flow to the thrombosed dialysis access graft. 
  • Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study. 
  • Rates of Medicare Enrollment Among Dialysis Patients After Implementation of Medicare Payment Reform and the Affordable Care Act Marketplace. 
  • Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). 
  • Re-evaluating the volume-outcome relationship in hemodialysis patients. 
  • Reconsidering Plant-Based Diets in Patients Receiving Maintenance Hemodialysis. 
  • Reducing the risk of hemodialysis access. 
  • Regarding "Radial artery deviation and reimplantation inhibits venous juxta-anastomotic stenosis and increases primary patency of radial-cephalic fistulas for hemodialysis". 
  • Regional and Racial Disparities in HIV-Related Kidney Disease. 
  • Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions. 
  • Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. 
  • Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. 
  • Relevance of B-Lines on Lung Ultrasound in Volume Overload and Pulmonary Congestion: Clinical Correlations and Outcomes in Patients on Hemodialysis. 
  • Religious involvement and health in dialysis patients in Saudi Arabia. 
  • Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts. 
  • Renal Recovery Years After Initial Diagnosis of Hemolytic Uremic Syndrome. 
  • Renal osteodystrophy: neurosurgical considerations and challenges. 
  • Renal systems biology of patients with systemic inflammatory response syndrome. 
  • Research issues in psychological studies of chronic dialysis. 
  • Resolution of nephrocalcinosis associated with tumor lysis syndrome. 
  • Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. 
  • Revascularization of the solitary kidney: a challenging problem in a high risk population. 
  • Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician. 
  • Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States. 
  • Risk factors for mortality in patients admitted to intensive care units with pneumonia. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Risk of Infective Endocarditis in Patients with End Stage Renal Disease. 
  • Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. 
  • Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis. 
  • Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. 
  • Salvaging vascular access and treatment of severe limb edema: case reports on the novel use of the hemodialysis reliable outflow vascular access device. 
  • Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. 
  • Scratching the itch: a new therapeutic target for dialysis-associated pruritus? 
  • Second chances in mineral metabolism. 
  • Sensitivity and specificity of the thermodilution technique in detection of access recirculation. 
  • Serious Fall Injuries Before and After Initiation of Hemodialysis Among Older ESRD Patients in the United States: A Retrospective Cohort Study. 
  • Serious Fall Injury History and Adverse Health Outcomes After Initiating Hemodialysis Among Older U.S. Adults. 
  • Seriously ill hospitalized adults: do we spend less on older patients? Support Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatments. 
  • Serological evidence of cross infection in a dialysis unit hepatitis-B epidemic. 
  • Shared decision-making in end-stage renal disease: a protocol for a multi-center study of a communication intervention to improve end-of-life care for dialysis patients. 
  • Shared patient and provider values in end-stage renal disease decision making: Identifying the tensions. 
  • Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. 
  • Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. 
  • Site of Care and Health Outcomes of Veterans Undergoing Maintenance Dialysis. 
  • Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients. 
  • Spiritual coping, religiosity and quality of life: a study on Muslim patients undergoing haemodialysis. 
  • Spirituality, Coping, and Resilience Among Rural Residents Living with Chronic Kidney Disease. 
  • Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful? 
  • Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations. 
  • Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes. 
  • State medicaid coverage, ESRD incidence, and access to care. 
  • State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statins at Dialysis Transition-Supportive but Not Sufficient. 
  • Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. 
  • Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. 
  • Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. 
  • Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial. 
  • Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. 
  • Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial. 
  • Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach. 
  • Sudden Cardiac Death Among Hemodialysis Patients. 
  • Sudden cardiac arrest in ESRD patients. 
  • Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk. 
  • Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome. 
  • Supply and Distribution of Vascular Access Physicians in the United States: A Cross-Sectional Study. 
  • Surgical aspects and biological considerations of arteriovenous fistula placement. 
  • Surgical excision of infected arteriovenous grafts: technique and review. 
  • Surveillance of fistula function by frequent recirculation measurements during high efficiency dialysis. 
  • Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings. 
  • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. 
  • Tear urea nitrogen and creatinine levels in renal patients. 
  • Technical innovation. Using a covered stent (wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. 
  • Technical innovation. Using a cutting balloon to treat resistant high-grade dialysis graft stenosis. 
  • Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry. 
  • Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. 
  • Test-retest reliability of the Muslim Religiosity Scale: follow-up to "Religious involvement and health among dialysis patients in Saudi Arabia". 
  • The ASCEND-ND trial: study design and participant characteristics. 
  • The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. 
  • The Effect of Holy Qur'an Recitation on Anxiety in Hemodialysis Patients: A Randomized Clinical Trial. 
  • The Effect of Holy Qur'an Recitation on Depressive Symptoms in Hemodialysis Patients: A Randomized Clinical Trial. 
  • The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and Outcomes. 
  • The MMPI as a measure of the emotional correlates of chronic hemodialysis: a review. 
  • The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. 
  • The burden of dialysis-requiring acute kidney injury among hospitalized adults with HIV infection: a nationwide inpatient sample analysis. 
  • The case against chronic venous hemodialysis access. 
  • The effect of aprotinin on outcome after coronary-artery bypass grafting. 
  • The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials. 
  • The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts. 
  • The effect of the Statewide Sharing variance on geographic disparity in kidney transplantation in the United States. 
  • The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. 
  • The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. 
  • The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. 
  • The experience and self-management of fatigue in patients on hemodialysis. 
  • The increasing prevalence of atrial fibrillation among hemodialysis patients. 
  • The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. 
  • The kidney in HIV infection: beyond HIV-associated nephropathy. 
  • The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. 
  • The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. 
  • The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran. 
  • The renal failure that vanished. 
  • The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults. 
  • The spectrum of infection-related morbidity in hospitalized haemodialysis patients. 
  • Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. 
  • Thrombosed polytetrafluoroethylene hemodialysis fistulas: salvage with combined thrombectomy and angioplasty. 
  • Thrombosed synthetic hemodialysis access fistulas: the success of combined thrombectomy and angioplasty (technical note). 
  • Thrombosis and the antiphospholipid syndrome. 
  • Timing of commencement of maintenance dialysis and mortality in young and older adults in Singapore. 
  • Tissue-engineered vascular grafts: autologous off-the-shelf vascular access? 
  • Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. 
  • Transhepatic catheter access for hemodialysis. 
  • Transplantation and the end-stage renal disease program. 
  • Treatment approaches for infected hemodialysis vascular catheters. 
  • Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment. 
  • Treatment of central venous in-stent restenosis with repeat stent deployment in hemodialysis patients. 
  • Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. 
  • Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. 
  • Trends in Dialysis Industry Consolidation After Medicare Payment Reform, 2006-2016. 
  • Trends in Mineral Metabolism Treatment Strategies in Patients Receiving Hemodialysis in the United States. 
  • Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis. 
  • Trends in anemia management in US hemodialysis patients 2004-2010. 
  • Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. 
  • Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. 
  • Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. 
  • Tunneled internal jugular hemodialysis catheters: impact of laterality and tip position on catheter dysfunction and infection rates. 
  • Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. 
  • Underreporting of nursing home utilization on the CMS-2728 in older incident dialysis patients and implications for assessing mortality risk. 
  • Understanding factors that influence the demand for dialysis among elderly in a multi-ethnic Asian society. 
  • Unusual cause of superior vena cava syndrome diagnosed with transesophageal echocardiography. 
  • Upper extremity computed tomographic angiography: state of the art technique and applications in 2010. 
  • Uremic tumoral calcinosis: preliminary observations suggesting an association with aberrant vitamin D homeostasis. 
  • Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. 
  • Use of aspirin associates with longer primary patency of hemodialysis grafts. 
  • Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. 
  • Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. 
  • Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass. 
  • Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. 
  • Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpedance technique. 
  • Validation of haemodialysis recirculation and access blood flow measured by thermodilution. 
  • Vanishing leg ulcers. 
  • Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019. 
  • Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Variations in levels of blood pressure: of prognostic value or not? 
  • Vascular Calcification Markers and Hemodialysis Vascular Access Complications. 
  • Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. 
  • Veterans more likely to start hemodialysis with an arteriovenous fistula. 
  • Vitamin D Receptor Agonists for Patients Undergoing Hemodialysis. 
  • Vitamin D in patients with kidney disease: cautiously optimistic. 
  • Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. 
  • Vitamin D levels and early mortality among incident hemodialysis patients. 
  • We still go for the jugular: implications of the 3SITES central venous catheter study for nephrology. 
  • When All You Have Is a Hammer: The Need for Tools to Define and Apply Patient-Centered Outcomes in Hemodialysis. 
  • Who may not benefit from continuous renal replacement therapy in acute kidney injury? 
  • Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. 
  • Withholding versus withdrawing life-sustaining treatment: patient factors and documentation associated with dialysis decisions. 
• 

  Keywords of People

  • Anderson, Ruth A., Professor Emerita in the School of Nursing, School of Nursing
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society